Replies to post #7674 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

It's like I've been saying....it's getting old, tired.

I think Merck is a horrible partner.

Either that, or they feel like they need to combine it with another one of their drugs for more efficacy (and more money for them).

[bellweather1]

Do you think it's possible they anticipate a combo strategy of an m-tor with another med may work better, and it's keeping them from commiting to a single drug trial, despite the great pII results.

Could it be that they think a multi target strategy(like Cris's) is more viable?

Don't know if anyone has such a trial(another m-tor plus something else, or a multitarget single drug)in the hopper for endo.

Do you?

Thoughts?